We are live on ! Find out more
WA

Wilshire Advisors Portfolio holdings

AUM $9.96M
1-Year Est. Return 76.57%
This Fund
S&P 500
This Quarter Est. Return
-1.2%
1 Year Est. Return
+76.57%
3 Year Est. Return
+100.3%
5 Year Est. Return
+82.67%
10 Year Est. Return
+137%
AUM
$11.6M
AUM Growth
-$27M
Cap. Flow
-$25.2M
Cap. Flow %
-217.21%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
5
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 7.26%
2 Financials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEFA icon
1
iShares Core MSCI EAFE ETF
IEFA
$186B
$4.19M 36.11%
46,863
-2,130
-4% -$188K
AGG icon
2
iShares Core US Aggregate Bond ETF
AGG
$138B
$2.38M 20.51%
23,842
-199
-0.8% -$20K
IGSB icon
3
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$1.8M 15.52%
34,075
+94
+0.3% +$4.98K
IJR icon
4
iShares Core S&P Small-Cap ETF
IJR
$109B
$1.75M 15.04%
14,532
-898
-6% -$107K
OMDA
5
Omada Health Inc
OMDA
$1.22B
$842K 7.26%
+53,383
New +$1.08M
IEMG icon
6
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$589K 5.07%
8,759
-506
-5% -$33.9K
LDI icon
7
loanDepot
LDI
$548M
$57.4K 0.49%
27,727
-5,496,925
-99% -$15.3M
FATE icon
8
Fate Therapeutics
FATE
$281M
-8,486,822
Closed -$10.7M

Similar funds

Wilshire Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Wilshire Advisors held 8 positions worth $11.6M, down 70% from $38.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Wilshire Advisors withdrew a net $25.2M in Q4 2025, closing 1 position and reducing 5 holdings. Its most notable exit was Fate Therapeutics, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.3% of assets, down from 28% a quarter earlier, followed by Financials.

Against the trend, Wilshire Advisors opened a new position in Omada Health Inc worth $842K.

  • Wilshire Advisors's largest Q4 2025 buy was Omada Health Inc: 53,383 shares worth $842K.
  • Wilshire Advisors added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q4 2025, an estimated $4.98K increase.
  • Wilshire Advisors's biggest Q4 2025 reduction was loanDepot, cutting an estimated $15.3M.
  • Wilshire Advisors fully exited Fate Therapeutics in Q4 2025, selling an estimated $10.7M.
  • Wilshire Advisors's ten largest holdings make up 100% of its $11.6M portfolio in Q4 2025.
  • Wilshire Advisors opened 1 new position and closed 1 in Q4 2025.
  • Wilshire Advisors's portfolio value fell 70% quarter-over-quarter to $11.6M.

Based on Wilshire Advisors's 13F filing for Q4 2025, filed 27 May 2026.